参考文献
1. Opdivo Prescribing Information. Opdivo U.S. Product Information. Last updated: May 2020. Princeton, NJ: Bristol Myers Squibb Company.
2. U.S. Food & Drug Administration. Real-Time Oncology Review Pilot Program. http://www.fda.gov/about-fda/oncology-center-excellence/real-time-oncology-review-pilot-program. Accessed May 18, 2019.
3. Reck M, Tudor-Eilade C, Cobo Dols M, et al. Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles of chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA [abstract]. In: American Society of Clinical Oncology (ASCO) Annual Meeting; May 29 – June 2, 2020; Virtual.
4. Yervoy Prescribing Information. Yervoy U.S. Product Information. Last updated: May 2020. Princeton, NJ: Bristol Myers Squibb Company.
5. National Cancer Institute. Non-Small Cell Lung Cancer Treatment (PDQ) – Health Professional Version. Updated May 7, 2020. Accessed May 18, 2020.
6. Weber J, Hamid Omid, Chasalow S, et al. Ipilimumab Increases Activated T Cells and Enhances Humoral Immunity in Patients with Advanced Melanoma. Journal of Immunotherapy. 2012;35(1):89-97.
7. Farber D, Yudanin N, Restifo N. Human Memory T Cells: Generation, Compartmentalization and Homeostatsis. Nature Reviews Immunology. 2014;14:24-35.
8. Ansell S, Hurvitz S, Keonig P, et al. Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma. American Association for Cancer Research. 2009;15(20):6446-6453.
9. Felix J, Lambert J, Roelens M, et al. Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response. Oncoimmunology. 2016;5(7):1-10.
10. Pedicord V, Montalvo W, Leiner I, et al. Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance. Proceedings of the National Academy of Sciences of the United States of America. 2011;8(1):266-271.
11. Pico de Coana Y, Wolodarski M, Poschke I, et al. Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cell sin long-term survivors with advanced melanoma. Oncotarget. 2017; 8(13):21539-21553.
12. SEER. Lung and Bronchus Cancer, CSR 1975-2016. http://seer.cancer.gov/statfacts/html/lungb.html Accessed May 18, 2020.
13. American Cancer Society. Key Statistics for Lung Cancer. http://www.cancer.org/cancer/lung-cancer/about/key-statistics.html. Accessed May 18, 2020.